FDA Approved Genentech’s Susvimo Eye Implants
FDA approved Genentech’s Susvimo, a port delivery system with a customized formulation of Ranibizumab, the active ingredient in Lucentis. Now, the trick for…
FDA approved Genentech’s Susvimo, a port delivery system with a customized formulation of Ranibizumab, the active ingredient in Lucentis. Now, the trick for…
Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their…
Synopsis- Aptar Pharma and i2c Pharmaceutical Services joins hand for co-develop and promote i2c’s pressurized metered dose inhaler (pMDI) technology, Respitab.…
MINUTES OF THE 432nd REGISTRATION COMMITTEE MEETING HELD ON 24.09.2021. The 432nd meeting of the Registration Committee (RC) was held under the…
Keypoints J&J presented data to the 19-member committee indicating that its vaccine loses efficacy over time, and that a booster shot is…
Key Points – AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges,…
MINUTES OF THE 431st REGISTRATION COMMITTEE MEETING HELD ON 27.08.2021. The 431st meeting of the Registration Committee (RC) was held under the…
MINUTES OF THE 430th REGISTRATION COMMITTEE MEETING HELD ON 23.07.2021 The 430th meeting of the Registration Committee (RC) was held under the…
MINUTES OF THE 429th REGISTRATION COMMITTEE MEETING HELD ON 24.06.2021, 28.06.2021, and 30.06.2021. The 429th meeting of the Registration Committee (RC) was…
MINUTES OF THE 428th REGISTRATION COMMITTEE MEETING HELD ON 18.05.2021 The 428thmeeting of the Registration Committee (RC) was held under the Chairmanship…